Harbour Investment Management LLC Sells 152 Shares of Danaher Co. (NYSE:DHR)

Harbour Investment Management LLC cut its position in shares of Danaher Co. (NYSE:DHR) by 1.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,817 shares of the conglomerate’s stock after selling 152 shares during the quarter. Harbour Investment Management LLC’s holdings in Danaher were worth $2,486,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Kentucky Retirement Systems Insurance Trust Fund grew its holdings in shares of Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after buying an additional 2,202 shares in the last quarter. ORG Partners LLC grew its stake in Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after purchasing an additional 2,559 shares in the last quarter. Generate Investment Management Ltd bought a new position in Danaher in the fourth quarter valued at approximately $8,044,000. Stifel Financial Corp grew its stake in Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares in the last quarter. Finally, Compass Capital Management Inc. grew its stake in Danaher by 4.8% in the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock valued at $54,615,000 after purchasing an additional 10,994 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 11.10% of the stock is owned by insiders.

Danaher Price Performance

Shares of NYSE DHR opened at $211.09 on Friday. The stock has a market capitalization of $150.87 billion, a PE ratio of 39.98, a P/E/G ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The business has a fifty day moving average price of $220.07 and a two-hundred day moving average price of $240.82. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the company posted $2.09 earnings per share. As a group, equities analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 24.24%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Guggenheim assumed coverage on Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 target price (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research note on Friday, December 13th. The Goldman Sachs Group set a $250.00 target price on Danaher in a research note on Wednesday, January 15th. Finally, Citigroup reduced their target price on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. Six investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $277.76.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.